Davis's Drug Guide
bezafibrate
General
Canada-Approved Medicine
This monograph describes a medication approved for use in Canada by the Therapeutic Products Directorate, a division of Health Canada’s Health Products and Food Branch. The medication is not approved by the United States Food and Drug Administration; however, a similar formulation carrying a different generic or brand name might be available in the US.
Pronunciation:
bezz-uh-fibe-rate
Trade Name(s)
- Bezalip SR
Ther. Class.
lipid-lowering agents
Pharm. Class.
fibric acid derivatives
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Bezafibrate." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580002/all/bezafibrate.
Vallerand AHA, Sanoski CAC, . Bezafibrate. Davis's Drug Guide. F.A. Davis Company; 2025. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580002/all/bezafibrate. Accessed January 15, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Bezafibrate. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580002/all/bezafibrate
Vallerand AHA, Sanoski CAC, . Bezafibrate [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 January 15]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580002/all/bezafibrate.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - bezafibrate
ID - 3580002
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580002/all/bezafibrate
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -
